Sign In
Buy ASND
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026
Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S (ASND)
12:25am, Monday, 23'rd Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Citigroup Inc. Has $495,000 Holdings in Ascendis Pharma A/S (NASDAQ:ASND)
10:24am, Sunday, 22'nd Mar 2020
Citigroup Inc. grew its position in Ascendis Pharma A/S (NASDAQ:ASND) by 196.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (
Banco Bilbao Vizcaya Argentaria S.A. Takes Position in Ascendis Pharma A/S (NASDAQ:ASND)
09:00am, Sunday, 22'nd Mar 2020
Banco Bilbao Vizcaya Argentaria S.A. purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND) during the fourth quarter, according to its most recent disclosure with the Securities & Excha
Ascendis Pharma A/S (NASDAQ:ASND) Expected to Post Quarterly Sales of $2.26 Million
05:46am, Sunday, 22'nd Mar 2020
Equities research analysts expect Ascendis Pharma A/S (NASDAQ:ASND) to announce sales of $2.26 million for the current quarter, Zacks Investment Research reports. Three analysts have made estimates fo
We're Hopeful That Ascendis Pharma (NASDAQ:ASND) Will Use Its Cash Wisely
12:49pm, Saturday, 21'st Mar 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Ascendis Pharma (ASND): Strong Industry, Solid Earnings Estimate Revisions
12:56pm, Friday, 20'th Mar 2020
Ascendis Pharma (ASND) has seen solid estimate revision activity over the past month, and belongs to a strong industry as well.
Ascendis Pharma (ASND): Strong Industry, Solid Earnings Estimate Revisions
12:56pm, Friday, 20'th Mar 2020
Ascendis Pharma (ASND) has seen solid estimate revision activity over the past month, and belongs to a strong industry as well.
Piper Sandler likes Gilead ahead of expected FDA nod for remdesivir for Covid-19
11:12am, Friday, 20'th Mar 2020
Ascendis Pharma (NASDAQ:ASND) initiated with Outperform rating with a $199 (97% upside) price target at Oppenheimer.Livongo Health (NASDAQ:LVGO) initiated with Buy rating and $30 (39% upside) price ta
ArrowMark Colorado Holdings LLC Invests $1.67 Million in Ascendis Pharma A/S (NASDAQ:ASND)
09:10am, Friday, 20'th Mar 2020
ArrowMark Colorado Holdings LLC purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 12,000 shares of the biotechnol
Ascendis Pharma (ASND) Received its Third Buy in a Row
08:14pm, Thursday, 19'th Mar 2020
After Cantor Fitzgerald and Morgan Stanley gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another Buy, this time from
Ascendis Pharma (ASND) Received its Third Buy in a Row
08:14pm, Thursday, 19'th Mar 2020
After Cantor Fitzgerald and Morgan Stanley gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another
Ascendis Pharma initiated with an Outperform at Oppenheimer ASND
09:08am, Thursday, 19'th Mar 2020
Ascendis Pharma initiated with an Outperform at Oppenheimer Oppenheimer ASND
